France to explore expenditure control through reimbursement
This article was originally published in Clinica
Executive Summary
France may soon have a new tool to control medical device expenditure within its reimbursement structure when spending levels raise concern. This will be achieved via the new French reimbursement pricing committee for medical devices, CEPS. And while it will need time to settle fully into its active role, the concept of price-volume agreements with manufacturers is unlikely to be far away.